Fertility and Sterility
Volume 94, Issue 4 , Pages 1239-1243 , September 2010

Perspectives of couples with high risk of transmitting genetic disorders

Presented as a poster presentation at the 64th Annual Meeting of the ASRM, November 10-12, 2008, San Francisco, California.

  • Anna M. Musters, M.D.

      Affiliations

    • Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands
    • Corresponding Author InformationReprint requests: Anna M. Musters, M.D., Center for Reproductive Medicine, Department of Obstetrics & Gynecology (H4-205), Academic Medical Center, University of Amsterdam, PO Box 22700, 1100 DE Amsterdam, the Netherlands (FAX: 31-20-6971651).
    • ,
  • Moniek Twisk, M.D.

      Affiliations

    • Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands
    • ,
  • Nico J. Leschot, M.D., Ph.D.

      Affiliations

    • Department of Clinical Genetics, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands
    • ,
  • Cor Oosterwijk, Ph.D.

      Affiliations

    • Dutch Genetic Alliance VSOP, Soest, the Netherlands
    • ,
  • Johanna C. Korevaar, Ph.D.

      Affiliations

    • Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Academic Medical Center University of Amsterdam, Amsterdam, the Netherlands
    • ,
  • Sjoerd Repping, Ph.D.

      Affiliations

    • Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands
    • ,
  • Fulco van der Veen, M.D., Ph.D.

      Affiliations

    • Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands
    • ,
  • Mariette Goddijn, Ph.D.

      Affiliations

    • Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands

Received 4 May 2009 ,Revised 20 July 2009 ,Accepted 7 August 2009.

References 

  1. Handyside AH, Kontogianni EH, Hardy K, Winston RM. Pregnancies from biopsied human preimplantation embryos sexed by Y-specific DNA amplification. Nature. 1990;344:768–770
  2. Blumberg BD, Golbus MS, Hanson KH. The psychological sequelae of abortion performed for a genetic indication. Am J Obstet Gynecol. 1975;122:799–808
  3. Donnai P, Charles N, Harris R. Attitudes of patients after “genetic” termination of pregnancy. Br Med J. 1981;282:621–622
  4. Lloyd J, Laurence KM. Sequelae and support after termination of pregnancy for fetal malformation. Br Med J. 1985;290:907–909
  5. Black RB. A 1 and 6 month follow-up of prenatal diagnosis patients who lost pregnancies. Prenat Diagn. 1989;9:795–804
  6. Kenyon SL, Hackett GA, Campbell S. Termination of pregnancy following diagnosis of fetal malformation: the need for improved follow-up services. Clin Obstet Gynecol. 1988;31:97–100
  7. Heckerling PS, Verp MS. Amniocentesis or chorionic villus sampling for prenatal genetic testing: a decision analysis. J Clin Epidemiol. 1991;44:657–670
  8. Elias S, Simpson JL. Amniocentesis and fetal blood sampling. In:  Milunsky A editors. Genetic disorders and the fetus. Baltimore: John Hopkins University Press; 2004;p. 66–99
  9. Fletcher JF. The ethics of genetic control: ending reproductive roulette. Buffalo, NY: Prometheus Books; 1998;
  10. Schieve LA, Meikle SF, Ferre C, Peterson HB, Jeng G, Wilcox LS. Low and very low birth weight in infants conceived with use of assisted reproductive technology. N Engl J Med. 2002;346:731–737
  11. Hansen M, Kurinczuk JJ, Bower C, Webb S. The risk of major birth defects after intracytoplasmic sperm injection and in vitro fertilization. N Engl J Med. 2002;346:725–730
  12. Ludwig AK, Sutcliffe AG, Diedrich K, Ludwig M. Post-neonatal health and development of children born after assisted reproduction: a systematic review of controlled studies. Eur J Obstet Gynecol Reprod Biol. 2006;127:3–25
  13. Corveleyn A, Zika E, Morris M, Dequeker E, Lawford Davies J, Sermon K, et al. Preimplantation genetic diagnosis in Europe. European Commission; Joint Research Centre; Institute for Prospective Technological Studies. Published in Spain by the office for official Publications of the European Communities 2008 ISBN 978-92-79-05654-3.
  14. Goossens V, Harton G, Moutou C, Scriven PN, Traeger-Synodinos J, Sermon K, et al. ESHRE PGD Consortium data collection VIII: cycles from January to December 2005 with pregnancy follow-up to October 2006. Hum Reprod. 2008;23:2629–2645
  15. Palomba ML, Monni G, Lai R, Cau G, Olla G, Cao A. Psychological implications and acceptability of preimplantation diagnosis. Hum Reprod. 1994;9:360–362
  16. Pergament E. Preimplantation diagnosis: a patient perspective. Prenat Diagn. 1991;11:493–500
  17. Chamayou S, Guglielmino A, Giambona A, Siciliano S, Di Stefano G, Scibilia G, et al. Attitude of potential users in Sicily towards preimplantation genetic diagnosis for beta-thalassaemia and aneuploidies. Hum Reprod. 1998;13:1936–1944
  18. Lavery SA, Aurell R, Turner C, Castellu C, Veiga A, Barri PN, et al. Preimplantation genetic diagnosis: patients' experiences and attitudes. Hum Reprod. 2002;12:2464–2467
  19. Hui PW, Lam YH, Chen M, Tang MH, Yeung WS, Ng EH, et al. Attitude of at-risk subjects towards preimplantation genetic diagnosis of alpha- and beta-thalassaemias in Hong Kong. Prenat Diagn. 2002;22:508–511
  20. Snowdon C, Green JM. Preimplantation diagnosis and other reproductive options: attitudes of male and female carriers of recessive disorders. Hum Reprod. 1997;12:341–350
  21. Twisk M, van der Veen F, Repping S, Heineman MJ. Preferences of subfertile women regarding elective single embryo transfer: additional in vitro fertilization cycles are acceptable, lower pregnancy rates are not. Fertil Steril. 2007;88:1006–1009
  22. Twisk M, Haadsma ML, van der Veen F, Repping S, Mastenbroek S, Heineman MJ, et al. Preimplantation genetic screening as an alternative to prenatal testing for Down syndrome: preferences of women undergoing in vitro fertilization/intracytoplasmic sperm injection treatment. Fertil Steril. 2007;88:804–810
  23. Franssen MT, Korevaar JC, van der Veen F, Boer K, Leschot NJ, Goddijn M. Management of recurrent miscarriage: evaluating the impact of a guideline. Hum Reprod. 2007;22:1298–1303

 A.M.M. has nothing to disclose. M.T. has nothing to disclose. N.J.L. has nothing to disclose. C.O. has nothing to disclose. J.C.K. has nothing to disclose. S.R. has nothing to disclose. F.v.d.V. has nothing to disclose. M.G. has nothing to disclose.

PII: S0015-0282(09)03488-8

doi: 10.1016/j.fertnstert.2009.08.025

Fertility and Sterility
Volume 94, Issue 4 , Pages 1239-1243 , September 2010

Article Tools